GEN1029 (HexaBody®-DR5/DR5) Safety Trial in Patients With Malignant Solid Tumors

Clinical trial NCT03576131 · TERMINATED

Trial details

NCT number: NCT03576131
Sponsor: Genmab
Status: TERMINATED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Colorectal Cancer Non-small Cell Lung Cancer Triple Negative Breast Cancer Renal Cell Carcinoma Gastric Cancer Pancreatic Cancer Urothelial Cancer

Start date: 2018-04-30
Primary completion: 2021-10-12
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.